Last Updated:2022/12/23
A biotechnology cancer drug cuts in half the risk that one type of breast cancer will recur after surgery.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories(0)
A biotechnology cancer drug cuts in half the risk that one type of breast cancer will recur after surgery.